tirzepatide salt form · Target ≥ 99.0% · Batch COA · LyoPep Tirzepatide Weight Loss Injections &

Using a U-100 insulin syringe for BPC-157 dosing gives you much finer control than a standard 1ml or 3ml syringe

What is AOD-9604?+ A GH fragment peptide studied for metabolic and body-composition effects

Safety Profile Comparison (2026 Data) Risk Factor Semaglutide (GLP-1) Bariatric Surgery Invasiveness Non-invasive (Injection) Invasive (Surgery) Common Risks Nausea, Vomiting, Constipation Infection, Bleeding, Blood Clots Serious Risks Pancreatitis, Gastroparesis Dumping Syndrome, Malnutrition Anesthesia Risk None Standard Surgical Risk Reversibility Fully Reversible Generally Permanent 2

BPC-157 is not a substitute for prescribed medical treatment

Back Brown, M, Goldstein, J, Podolsky, DK, et al (1 Sept 2020) 'In Memoriam: Dr

Managing Side Effects Effective management of side effects is crucial for maintaining the overall treatment efficacy